Factor Xa Signaling Contributes to the Pathogenesis of Inflammatory Diseases

Safieh Ebrahimi1, Sara Rezaei1, Parvaneh Seiri1

  • 1Department of Medical Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Insights

Factor Xa (FXa) triggers signaling pathways involved in inflammatory diseases like fibrosis, cardiovascular disease, and cancer. Understanding FXa signaling mechanisms is crucial for developing treatments for these disorders.

Area of Science:

  • Biochemistry
  • Cellular Biology
  • Medical Science

Background:

  • Factor Xa (FXa) is a coagulation protease.
  • FXa activates protease-activated receptors (PARs) and non-PAR receptors, initiating signaling pathways.
  • FXa-mediated signaling is implicated in inflammatory diseases, including fibrosis, cardiovascular diseases, and cancer.

Purpose of the Study:

  • To review the current knowledge on FXa signaling mechanisms.
  • To understand FXa's role in cellular and animal systems under physiological and pathological conditions.
  • To provide insights for better management of FXa-induced disorders.

Main Methods:

  • Literature review of existing studies on FXa signaling.
  • Analysis of cellular and animal models investigating FXa's function.
  • Synthesis of current understanding of FXa's role in disease pathogenesis.

Main Results:

  • FXa signaling contributes to the pathogenesis of multiple inflammatory conditions.
  • Targeting FXa presents significant clinical potential for treating these disorders.
  • A comprehensive understanding of FXa signaling is essential for therapeutic development.

Conclusions:

  • FXa plays a critical role in various signaling pathways relevant to disease.
  • Inhibition of FXa holds therapeutic promise for inflammatory diseases.
  • Further research into FXa signaling mechanisms will facilitate improved clinical management.

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K